Top 9 manufacturers in Myocardial Infarction Treatment Market
Updated 01:00:18 March 08, 2020
Prof Resear published a new Market report on Myocardial Infarction Treatment Market. It present the largest 9 manufacruers in Myocardial Infarction Treatment Market. The report is a professional and in-depth study on the current state of the global Myocardial Infarction Treatment market with a focus on the Chinese market. The report provides key statistics on market of Myocardial Infarction Treatment. It is a valuable source of guidance and direction for companies and individuals interested in Myocardial Infarction Treatment industry.
.
Bayer
Ref A: 026290DA6D6B4185AAB7ED48E1665A14 Ref B: SJCEDGE0415 Ref C: 2020-03-07T17:00:03Z
Novartis
Novartis Corporate History Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products. See the company profile for Novartis AG (NVS) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ... Read the Novartis company overview, including the company fact sheet, corporate responsibility, corporate governance and more. Read the Novartis company overview, including the company fact sheet, corporate responsibility, corporate governance and more.
Daiichi Sankyo
Company Profile Founded on September 28, 2005 through the merger of Daiichi Pharmaceutical and Sankyo , Daiichi Sankyo delivers innovative products that enhance the lives of … Company Profile Daiichi Sankyo , Inc. is the U.S. headquarters of Tokyo-based Daiichi Sankyo , Co ., Ltd. and a member of the Daiichi Sankyo Group , which spans 20 countries. Daiichi Sankyo , About Us, Company Profile , Company information. Daiichi Sankyo Healthcare Co., Ltd. Business Description: Manufacturing and purchase/sale of pharmaceuticals, over-the-counter products, cosmetics, medical equipment, food products and drinking water
Boehringer Ingelheim
Ref A: 622983E4E26C49ADB7C5F3EC9E90A3AA Ref B: SJCEDGE0213 Ref C: 2020-03-07T17:00:10Z
Astrazeneca
Ref A: 6D241A9271274CFE9368CBDC54B7D586 Ref B: SJCEDGE0416 Ref C: 2020-03-07T17:00:12Z
Janssen Biotech
Ref A: 4BABE8BA8E5A442FAC06A824530BB564 Ref B: SJCEDGE0216 Ref C: 2020-03-07T17:00:14Z
Merck
Ref A: 0B673632C050438FAC9CCF8F6A0EC9F7 Ref B: SJCEDGE0217 Ref C: 2020-03-07T17:00:16Z
Sanofi
We, at Sanofi , are there beside people in need, as a health journey partner. Discover Sanofi at a glance. 100,000+ employees in 100 countries. €5,894 million. invested in R&D in 2018. 84. projects in clinical development. Healthcare solutions. Life is a health journey with its ups and downs, and its challenges. These can be big or small ... Oct 31, 2019 · Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. Sanofi SA Sanofi manufactures pharmaceutical products. The Company offers drugs, generic medicines, food supplement, cosmetics, and medical devices such as …
Pfizer
Ref A: D8008E144B3447E0A79BFFE5FE412FD5 Ref B: SJCEDGE0417 Ref C: 2020-03-07T17:00:17Z